Vivosonic Inc. is a leader in the development of innovative technologies to enhance auditory evoked response detection. The Company develops, manufactures and markets medical devices for auditory diagnostic measurement and newborn hearing screening which are sold through a global distributor network in over 55 countries. Vivosonic invests heavily in research and development (R&D) to investigate new applications for its technology in audiology and other clinical specialties. The Company’s core competencies in advanced signal processing and filtering techniques for the analysis of electrophysiological responses offer a clear competitive advantage. Vivosonic is recognized in the industry for developing unique and effective solutions to the everyday challenges faced by healthcare professionals.
Vivosonic products are designed to improve clinical efficiency and patient care. The unique benefits of Vivosonic’s technological innovations in audiology have been clinically validated by leading hospitals, clinics, universities, and research institutions. Practitioners and researchers report significant advantages over conventional auditory brainstem response (ABR / BERA) equipment including a significant reduction in the need for sedation, more convenient scheduling of assessments, reduction in wait times, more reliable testing in the NICU and Operating Room (OR), and improved patient safety and comfort.
The Integrity™ V500 System is the only auditory evoked potential device with convenient wireless capabilities. Portable and easy to use, Integrity™ provides superior response detection in a greater range of environments, clinical populations and patient states. Patented and proprietary technologies significantly reduce the need for sedation during ABR measurement and enable testing in electrically noisy environments such as the NICU and OR. Aurix™ Newborn Hearing Screening System with automated ABR facilitates fewer rescreens and screening of high-risk infants in the NICU.
Since 1999, Vivosonic’s R&D activities have produced technological advancements that make it possible to obtain an earlier diagnosis, and test more patients, in more places.
VivoLink™ wireless capabilities for freedom of movement during testing.
Patented award-winning Amplitrode®, a combination of electrode and pre-amplifier for maximum noise reduction.
Proprietary noise-reducing algorithm (SOAP™-Kalman) techniques for advanced signal processing of evoked potentials.
The Company maintains an extensive Quality Management System conforming to ISO 13485 standards. As a manufacturer pioneering advancements in healthcare technology, Vivosonic is dedicated to the continuous improvement of their products and services through ongoing R&D in collaboration with customers and key opinion leaders. Recognized in the industry for its innovative solutions to every day clinical problems and for providing exceptional customer service, Vivosonic continues to help transform healthcare around the world.
